Evidence map›Paper›PMID 23416045›Full record

ArticleNeurochemistry international2013

Cdk5 regulates Rap1 activity.

Elias Utreras, Daniel Henriquez, Erick Contreras-Vallejos, Cristina Olmos, Alex Di Genova, Alejandro Maass, Ashok B Kulkarni, Christian Gonzalez-Billault

Open access · greenAbstract read
In one paragraph

Article in Neurochemistry international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. The Role of Cdk5 in Alzheimer's Disease.Molecular neurobiology · 2016
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Neuronal migration and protein kinases.Frontiers in neuroscience · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Elias UtrerasLaboratory of Cellular and Neuronal Dynamics, Department of Biology, Faculty of Sciences, Universidad de Chile, Chile.
Daniel Henriquez
Erick Contreras-Vallejos
Cristina Olmos
Alex Di Genova
Alejandro Maass
Ashok B Kulkarni
Christian Gonzalez-Billault
University of Chile · CLNational Institute of Dental and Craniofacial Research · US

Funding

Molecular Roles of Cdk5 in Neuronal Functions and Pain SignalingZIADE000664 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI KULKARNI, ASHOK · 2009 to 2025
$20.4M
PHOSPHORYLATION OF NEURONAL CYTOSKELETON IN NEURODEGENERATIVE DISEASESZ01DE000664 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI KULKARNI, ASHOK B. · 1996 to 2008
$1.5M
Intramural NIH HHS Z01 DE000664
6 · The paper itself

Abstract

Rap1 signaling is important for migration, differentiation, axonal growth, and during neuronal polarity. Rap1 can be activated by external stimuli, which in turn regulates specific guanine nucleotide exchange factors such as C3G, among others. Cdk5 functions are also important to neuronal migration and differentiation. Since we found that pharmacological inhibition of Cdk5 by using roscovitine reduced Rap1 protein levels in COS-7 cells and also C3G contains three putative phosphorylation sites for Cdk5, we examined whether the Cdk5-dependent phosphorylation of C3G could affect Rap1 expression and activity. We co-transfected C3G and tet-OFF system for p35 over-expression, an activator of Cdk5 activity into COS-7 cells, and then we evaluated phosphorylation in serine residues in C3G by immunoprecipitation and Western blot. We found that p35 over-expression increased C3G-serine-phosphorylation while inhibition of p35 expression by tetracycline or inhibition of Cdk5 activity with roscovitine decreased it. Interestingly, we found that MG-132, a proteasome inhibitor, rescue Rap1 protein levels in the presence of roscovitine. Besides, C3G-serine-phosphorylation and Rap1 protein levels were reduced in brain from Cdk5(-/-) as compared with the Cdk5(+/+) brain. Finally, we found that p35 over-expression increased Rap1 activity while inhibition of p35 expression by tetracycline or roscovitine decreased Rap1 activity. These results suggest that Cdk5-mediated serine-phosphorylation of C3G may control Rap1 stability and activity, and this may potentially impact various neuronal functions such as migration, differentiation, and polarity.

Indexed as

Amino Acid SequenceAnimalsBlotting, WesternChlorocebus aethiopsCOS CellsCyclin-Dependent Kinase 5Cysteine Proteinase InhibitorsGuanine Nucleotide-Releasing Factor 2ImmunoprecipitationInterleukin-12 Subunit p35LeupeptinsMembrane Fusion ProteinsMiceMice, KnockoutMolecular Sequence DataNeuronsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeCyclin-Dependent Kinase 5Cysteine Proteinase InhibitorsGuanine Nucleotide-Releasing Factor 2Interleukin-12 Subunit p35LeupeptinsMembrane Fusion Proteinsrap1 GTP-Binding ProteinsTetracycline

Identifiers

PMID23416045
PMCPMC3791512
OpenAlexW1976216689

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.